Biogen competitorsClear all

Biogen's top competitors include Shire, Bayer, Amgen, Gilead Sciences and Regeneron Pharmaceuticals.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Shire
Shire
Shire is a specialty biopharmaceutical company.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and agriculture.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is engaged in the development of human therapeutic products.
Gilead Sciences
Gilead Sciences
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines for the treatment of serious medical conditions.
Founding Date
Founding Date
1978
Founding Date
1986
Founding Date
1863
Founding Date
1980
Founding Date
1987
Founding Date
1988
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Vicente López, AR
North Ryde, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Locations
Dublin, IE HQ
The Rocks, AU
Wien, AT
Bruxelles, BE
Sofia, BG
see more
Locations
Leverkusen, DE HQ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
Minsk, BY
see more
Locations
Thousand Oaks, US HQ
Ben Aknoun, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Diegem, BE
see more
Locations
Foster City, US HQ
El Segundo, US
Emeryville, US
Miami, US
Oceanside, US
San Dimas, US
Santa Monica, US
see more
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Greater London, GB
Bernards, US
Rensselaer, US
Washington, US
Employees
Employees
7,8007% increase
Employees
23,044
Employees
109,0636% decrease
Employees
21,5003% increase
Employees
11,00010% increase
Employees
7,40019% increase
Valuation ($)
Valuation ($)
51.6 b
Valuation ($)
54.8 b
Valuation ($)
113.3 b
Valuation ($)
143.6 b
Valuation ($)
80 b
Valuation ($)
42.9 b
Twitter followers
Twitter followers
28.3 k
Twitter followers
7.7 k
Twitter followers
168.4 k
Twitter followers
82.4 k
Twitter followers
37.5 k
Twitter followers
15.9 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
65
Number of tweets (last 30 days)
51
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
22
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
13.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
5
Average likes per tweet (last 30 days)
8.3
Average likes per tweet (last 30 days)
14.5
Average likes per tweet (last 30 days)
9.2
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
52.31%
Percentage of tweets with engagement (last 30 days)
92.16%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
83540
Alexa Website Rank
333836
Alexa Website Rank
73126
Alexa Website Rank
269127
Alexa Website Rank
172460
Alexa Website Rank
183344

Financial

Revenue (est.)
Revenue (est.)
$11.4b (FY, 2016)
Revenue (est.)
£43m (FY, 2018)
Revenue (est.)
€39.6b (FY, 2018)
Revenue (est.)
$23.7b (FY, 2018)
Revenue (est.)
$22.1b (FY, 2018)
Revenue (est.)
$6.7b (FY, 2018)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€17b (FY, 2018)
Cost of goods
$4.1b (FY, 2018)
Cost of goods
$4.9b (FY, 2018)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
€22.6b (FY, 2018)
Gross profit
$19.6b (FY, 2018)
Gross profit
$17.3b (FY, 2018)
Gross profit
N/A
Net income
Net income
$3.7b (FY, 2016)
Net income
£3.4m (FY, 2018)
Net income
€1.7b (FY, 2018)
Net income
$8.4b (FY, 2018)
Net income
$5.5b (FY, 2018)
Net income
$2.4b (FY, 2018)

Operating

Countries
Countries
N/A
Countries
100 (FY, 2017)
Countries
153 (FY, 2018)
Countries
N/A
Countries
30 (FY, 2016)
Countries
N/A
Phase I Trials Products
Phase I Trials Products
4 (FY, 2016)
Phase I Trials Products
7 (FY, 2017)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
3 (FY, 2016)
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
10 (FY, 2016)
Phase II Trials Products
10 (FY, 2017)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
12 (FY, 2016)
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
15 (FY, 2017)
Phase III Trials Products
17 (FY, 2015)
Phase III Trials Products
N/A
Phase III Trials Products
6 (FY, 2016)
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
N/A
Total funding raised
$ 8.9m
For sources of this data, please see the company profile

View company profiles

Shire
HQ
Dublin, IE
Employees
23,044

Shire is a specialty biopharmaceutical company.

View company
Bayer
HQ
Leverkusen, DE
Employees
109,063↓ 6% decrease

Bayer is a global life science company specializing in healthcare and agriculture.

View company
Amgen
HQ
Thousand Oaks, US
Employees
21,500↑ 3% increase

Amgen (formerly known as Applied Molecular Genetics) is engaged in the development of human therapeutic products.

View company
Gilead Sciences
HQ
Foster City, US
Employees
11,000↑ 10% increase

Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines.

View company